- Home
- HCWB vs ADIL Comparison
HCWB vs ADIL Comparison
Compare HCWB & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- ADIL
- Stock Information
- Founded
- HCWB 2018
- ADIL 2010
- Country
- HCWB United States
- ADIL United States
- Employees
- HCWB N/A
- ADIL N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- HCWB Health Care
- ADIL Health Care
- Exchange
- HCWB Nasdaq
- ADIL Nasdaq
- Market Cap
- HCWB 8.7M
- ADIL 7.7M
- IPO Year
- HCWB 2021
- ADIL 2018
- Fundamental
- Price
- HCWB $4.00
- ADIL $0.38
- Analyst Decision
- HCWB Strong Buy
- ADIL Strong Buy
- Analyst Count
- HCWB 1
- ADIL 2
- Target Price
- HCWB $35.00
- ADIL $4.75
- AVG Volume (30 Days)
- HCWB 1.3M
- ADIL 737.3K
- Earning Date
- HCWB 11-13-2025
- ADIL 11-12-2025
- Dividend Yield
- HCWB N/A
- ADIL N/A
- EPS Growth
- HCWB N/A
- ADIL N/A
- EPS
- HCWB N/A
- ADIL N/A
- Revenue
- HCWB $832,841.00
- ADIL N/A
- Revenue This Year
- HCWB $178.64
- ADIL N/A
- Revenue Next Year
- HCWB N/A
- ADIL N/A
- P/E Ratio
- HCWB N/A
- ADIL N/A
- Revenue Growth
- HCWB N/A
- ADIL N/A
- 52 Week Low
- HCWB $2.77
- ADIL $0.22
- 52 Week High
- HCWB $100.80
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- HCWB 47.15
- ADIL 59.20
- Support Level
- HCWB $3.66
- ADIL $0.33
- Resistance Level
- HCWB $4.13
- ADIL $0.41
- Average True Range (ATR)
- HCWB 0.21
- ADIL 0.02
- MACD
- HCWB 0.00
- ADIL 0.01
- Stochastic Oscillator
- HCWB 34.60
- ADIL 74.89
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.